Kerkhoff C, Trümbach B, Gehring L, Habben K, Schmitz G, Kaever V
Institute of Pharmacology, Medical School Hannover, Germany.
Eur J Biochem. 2000 Nov;267(21):6339-45. doi: 10.1046/j.1432-1327.2000.01724.x.
In the present study, we defined experimental conditions that allowed the extraction of the integral membrane protein lysophospholipid:acyl-CoA acyltransferase (LAT, EC 2.3.1.23) from membranes while maintaining the full enzyme activity using the nonionic detergent n-octyl glucopyranoside (OGP) and solutions of high ionic strength. We found that the optimal OGP concentration depended on the ionic strength of the solubilization buffer. Fluorescence measurements with 1,6-diphenyl-1,3,5-hexatriene indicated that the critical micellar concentration (CMC) of OGP decreased with increasing salt concentrations. Analogous studies revealed that the zwitterionic detergent Chaps was ineffective in extracting LAT from membranes in the absence of salt, whereas its solubilization efficiency increased with increasing salt concentrations. Detailed lipid analysis of the different protein/lipid/detergent mixed micelles showed that the protein/lipid/OGP mixed micelles were relatively enriched with sphingomyelin (SPM) compared to protein/lipid/Chaps mixed micelles, indicating that the differences in the solubilization efficiency may be due to the ability to extract more SPM from membranes. When the protein/lipid/OGP mixed micelles were dissociated into protein/detergent and lipid/detergent complexes by the addition of increasing Chaps concentrations, one-tenth of the LAT enzyme activity was preserved making the enzyme accessible to protein purification. Analysis by native PAGE revealed that in the presence of excess Chaps a high molecular mass protein complex migrated into the gel which could be photolabeled by 125I-labelled-18-(4'-azido-2'-hydroxybenzoylamino)-oleyl-CoA. This fatty acid analogue has been shown to be a competitive inhibitor of LAT enzyme activity in the dark, and an irreversible inhibitor after photolysis. Therefore, this protein complex is assumed to contain the LAT enzyme.
在本研究中,我们确定了实验条件,可在使用非离子去污剂正辛基吡喃葡萄糖苷(OGP)和高离子强度溶液的情况下,从膜中提取完整膜蛋白溶血磷脂:酰基辅酶A酰基转移酶(LAT,EC 2.3.1.23),同时保持酶的全部活性。我们发现,最佳OGP浓度取决于溶解缓冲液的离子强度。用1,6 - 二苯基 - 1,3,5 - 己三烯进行的荧光测量表明,OGP的临界胶束浓度(CMC)随盐浓度的增加而降低。类似研究表明,两性离子去污剂Chaps在无盐情况下从膜中提取LAT无效,而其溶解效率随盐浓度增加而提高。对不同蛋白质/脂质/去污剂混合胶束的详细脂质分析表明,与蛋白质/脂质/Chaps混合胶束相比,蛋白质/脂质/OGP混合胶束相对富含鞘磷脂(SPM),这表明溶解效率的差异可能是由于从膜中提取更多SPM的能力不同。当通过增加Chaps浓度将蛋白质/脂质/OGP混合胶束解离成蛋白质/去污剂和脂质/去污剂复合物时,保留了十分之一的LAT酶活性,使该酶可用于蛋白质纯化。天然PAGE分析表明,在过量Chaps存在下,一种高分子量蛋白质复合物迁移到凝胶中,该复合物可用125I标记的18 -(4'-叠氮基 - 2'-羟基苯甲酰氨基) - 油酰辅酶A进行光标记。这种脂肪酸类似物在黑暗中已被证明是LAT酶活性的竞争性抑制剂,光解后是不可逆抑制剂。因此,假定该蛋白质复合物含有LAT酶。